Virtu KCG Holdings’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $106K | Sell |
38,515
-55,320
| -59% | -$152K | ﹤0.01% | 2388 |
|
|
2017
Q1 | $283K | Buy |
93,835
+78,390
| +508% | +$236K | 0.01% | 1996 |
|
|
2016
Q4 | $49K | Buy |
15,445
+1,751
| +13% | +$5.56K | ﹤0.01% | 3068 |
|
|
2016
Q3 | $47K | Sell |
13,694
-44,652
| -77% | -$153K | ﹤0.01% | 2776 |
|
|
2016
Q2 | $133K | Buy |
+58,346
| New | +$133K | ﹤0.01% | 2460 |
|
|
2016
Q1 | – | Sell |
-44,509
| Closed | -$147K | – | 3051 |
|
|
2015
Q4 | $147K | Buy |
44,509
+26,994
| +154% | +$89.2K | ﹤0.01% | 2343 |
|
|
2015
Q3 | $42K | Sell |
17,515
-97,779
| -85% | -$234K | ﹤0.01% | 2549 |
|
|
2015
Q2 | $338K | Buy |
115,294
+99,324
| +622% | +$291K | 0.01% | 1534 |
|
|
2015
Q1 | $64K | Buy |
+15,970
| New | +$64K | ﹤0.01% | 2264 |
|
|
2014
Q4 | – | Sell |
-86,618
| Closed | -$220K | – | 3059 |
|
|
2014
Q3 | $220K | Buy |
86,618
+27,651
| +47% | +$70.2K | ﹤0.01% | 1966 |
|
|
2014
Q2 | $145K | Buy |
+58,967
| New | +$145K | ﹤0.01% | 2186 |
|
|
2014
Q1 | – | Sell |
-87,700
| Closed | -$255K | – | 2581 |
|
|
2013
Q4 | $255K | Buy |
+87,700
| New | +$255K | ﹤0.01% | 1692 |
|